Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2025 Jun 1;6(3):e70071.
doi: 10.1002/jha2.70071. eCollection 2025 Jun.

A Comparative Study of the Outcomes of Surgically Versus Non-Surgically Treated Spinal Disease in Patients With Multiple Myeloma: Northern Ireland's Experience

Affiliations

A Comparative Study of the Outcomes of Surgically Versus Non-Surgically Treated Spinal Disease in Patients With Multiple Myeloma: Northern Ireland's Experience

Amber McCalmont et al. EJHaem. .

Abstract

Background: Multiple myeloma is a haematological malignancy which is characterised by the proliferation of cancerous plasma cells in the bone marrow. The role of spinal surgery in the management of myeloma is debatable. Therefore, this retrospective study aimed to compare the outcomes of treatment of patients with myeloma whose spinal disease was managed surgically and/or non-surgically.

Methods: A total of 159 patients were reviewed retrospectively. To compare the outcomes of treatment in both cohorts, three outcome measures were selected, including back-pain reduction, neurological status, and survival duration. In addition, the extent and distribution of vertebral disease was assessed using MRI Whole Spine reports.

Results: There was no significant difference in the percentage of patients in each cohort reporting back-pain pretreatment and at the two follow-up periods (p > 0.05). Regarding neurological status, 23% of the surgical cohort improved, 53% remained stable and 7% deteriorated. In comparison, the non-surgical cohort displayed no significant changes in neurological status post-treatment. The mean duration of survival was significantly longer in the cohort who received surgery (77 vs. 24 months, p = 0.014). However, the mean age of diagnosis was significantly lower in this cohort (59 vs. 71 years, p < 0.001). T12 was the most commonly diseased vertebral level across both cohorts. At the time of diagnosis, the average number of diseased vertebrae per patient was 3.5 in the surgical cohort and 3.6 in the non-surgical cohort.

Conclusion: This comparative study has shown that back pain alone should not be an indication for spinal surgery. However, surgical intervention may successfully prevent neurological deterioration. Although surgical intervention is associated with prolonged survival, this may be confounded by demographic variables, such as age. Importantly, most patients displayed multi-level disease at the time of diagnosis.

Trial registration: The authors have confirmed clinical trial registration is not needed for this submission.

Keywords: multiple myeloma; spinal disease; spinal surgery.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflicts of interest.

Figures

FIGURE 1
FIGURE 1
A flowchart to demonstrate how the surgical cohort was formed after inclusion and exclusion criteria were applied.
FIGURE 2
FIGURE 2
A flowchart to display the application of inclusion and exclusion criteria to the non‐surgical cohort of patients.
FIGURE 3
FIGURE 3
A bar chart to display the percentage of patients in each cohort whose pain persisted or did not improve at follow‐up.
FIGURE 4
FIGURE 4
A pie chart to display the change in neurological status of the patients in the surgical cohort 6 months postoperatively.
FIGURE 5
FIGURE 5
A bar chart to show the vertebrae which were diseased in the surgical and non‐surgical cohorts. The MRI scans performed prior to surgery detailed which levels were affected.

Similar articles

References

    1. Terpos E., Ntanasis‐Stathopoulos I., Gavriatopoulou M., and Dimopoulos M. A., “Pathogenesis of Bone Disease in Multiple Myeloma: From Bench to Bedside,” Blood Cancer Journal 8, no. 1 (2018): 1–12. - PMC - PubMed
    1. Nandra T. K., Devi A., and Jones J. R., “Multiple Myeloma: What a Non‐Haematologist Should Know,” Clinical Medicine 22, no. 3 (2022): 230. - PMC - PubMed
    1. Molloy S., Lai M., Pratt G., et al., “Optimizing the Management of Patients With Spinal Myeloma Disease,” British Journal of Haematology 171, no. 3 (2015): 332–343. - PubMed
    1. Ramsenthaler C., Kane P., Gao W., et al., “Prevalence of Symptoms in Patients With Multiple Myeloma: A Systematic Review and Meta‐Analysis,” European Journal of Haematology 97, no. 5 (2016): 416–429. - PubMed
    1. Jonsson B., Sjöström L., HalldÓR Jónsson J., and Karlström G., “Surgery for Multiple Myeloma of the Spine: A Retrospective Analysis of 12 Patients,” Acta Orthopaedica Scandinavica 63, no. 2 (2009): 192–194. - PubMed

LinkOut - more resources